YKL-40 as a new promising prognostic marker of severity in COVID infection

Crit Care. 2021 Feb 16;25(1):66. doi: 10.1186/s13054-020-03383-7.

Authors

Lauranne Schoneveld¹, Aurélie Ladang¹, Monique Henket², Anne-Noëlle Frix², Etienne Cavalier^#³, Julien Guiot^#²; COVID-19 clinical investigators of the CHU de Liège

Collaborators

COVID-19 clinical investigators of the CHU de Liège:
L Schoneveld, A Ladang, M Henket, A Frix, E Cavalier, J Guiot, A Ancion, J Berg, O Bonhomme, A Bouquegneau, C Bovy, S Bruls, G Darcis, J O Defraigne, A Ghuysen, A Gilbert, V Heinen, B Lambermont, R Louis, O Malaise, M Martin, B Misset, M Moutschen, D Nguyen Dang, J Piazza, D Szecel, J Szecel, H Van Cauwenberge, C Von Frenckell, L Vroonen

Affiliations

¹ Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium.
² Department of Pneumology, CHU de Liège, Liège, Belgium.
³ Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium. etienne.cavalier@chuliege.be.

^# Contributed equally.

No abstract available

Keywords: COVID-19; Chitinase 3-like 1; Interstitial lung disease; SARS-CoV-2; YKL-40.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Biomarkers / blood
COVID-19 / blood*
COVID-19 / therapy*
Chitinase-3-Like Protein 1 / blood*
Female
Humans
Intensive Care Units / statistics & numerical data
Male
Middle Aged
Patient Admission / statistics & numerical data
Prognosis
Retrospective Studies
Severity of Illness Index*

Substances

Biomarkers
CHI3L1 protein, human
Chitinase-3-Like Protein 1